References
1. Katz RM. Rhinitis in the athlete. J Allergy Clin Immunol. 1984;73(5 Pt 2):708-11.
2. Spence L, Brown WJ, Pyne DB, Nissen MD, Sloots TP, McCormack JG, et al. Incidence, etiology, and symptomatology of upper respiratory illness in elite athletes. Medicine and science in sports and exercise. 2007;39(4):577-86.
3. Walker AC, Surda P, Rossiter M, Little SA. Nasal disease and quality of life in athletes. J Laryngol Otol. 2018;132(9):812-5.
4. Bougault V, Turmel J, Boulet LP. Effect of intense swimming training on rhinitis in high-level competitive swimmers. ClinExpAllergy. 2010;40(8):1238-46.
5. Steelant B, Hox V, Van Gerven L, Dilissen E, Dekimpe E, Kasran A, et al. Nasal symptoms, epithelial injury and neurogenic inflammation in elite swimmers. Rhinology. 2018;56(3):279-87.
6. Classifying recommendations for clinical practice guidelines. Pediatrics. 2004;114(3):874-7.
7. Wang de Y, Lee HP, Gordon BR. Impacts of fluid dynamics simulation in study of nasal airflow physiology and pathophysiology in realistic human three-dimensional nose models. Clinical and experimental otorhinolaryngology. 2012;5(4):181-7.
8. Recinto C, Efthemeou T, Boffelli PT, Navalta JW. Effects of Nasal or Oral Breathing on Anaerobic Power Output and Metabolic Responses. International journal of exercise science. 2017;10(4):506-14.
9. Meir R, Zhao GG, Zhou S, Beavers R, Davie A. The acute effect of mouth only breathing on time to completion, heart rate, rate of perceived exertion, blood lactate, and ventilatory measures during a high-intensity shuttle run sequence. Journal of strength and conditioning research. 2014;28(4):950-7.
10. Campbell AP, Hoehle LP, Phillips KM, Caradonna DS, Gray ST, Sedaghat AR. Depressed mood is associated with loss of productivity in allergic rhinitis. Allergy. 2018;73(5):1141-4.
11. Canonica GW, Mullol J, Pradalier A, Didier A. Patient perceptions of allergic rhinitis and quality of life: findings from a survey conducted in europe and the United States. The World Allergy Organization journal. 2008;1(9):138-44.
12. Khan A, Huynh TMT, Vandeplas G, Joish VN, Mannent LP, Tomassen P, et al. The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life. Rhinology. 2019;57(5):343-51.
13. Katelaris CH, Carrozzi FM, Burke TV, Byth K. A springtime olympics demands special consideration for allergic athletes. J Allergy Clin Immunol. 2000;106(2):260-6.
14. Walker A, Surda P, Rossiter M, Little S. Rhinitis in Elite and Non-Elite Field Hockey Players. International journal of sports medicine. 2017;38(1):65-70.
15. Surda P, Putala M, Siarnik P, Walker A, Bernic A, Fokkens W. Rhinitis and its impact on quality of life in swimmers. Allergy. 2018;73(5):1022-31.
16. Salem L, Dao VA, Shah-Hosseini K, de Marees M, Mester J, Mosges R, et al. Impaired sports performance of athletes suffering from pollen-induced allergic rhinitis: a cross-sectional, observational survey in German athletes. The Journal of sports medicine and physical fitness. 2019;59(4):686-92.
17. Silvers WS, Poole JA. Exercise-induced rhinitis: a common disorder that adversely affects allergic and nonallergic athletes. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2006;96(2):334-40.
18. Roxbury CR, Qiu M, Shargorodsky J, Lin SY. Association between allergic rhinitis and poor sleep parameters in U.S. adults. Int Forum Allergy Rhinol. 2018;8(10):1098-106.
19. Watson AM. Sleep and Athletic Performance. Curr Sports Med Rep. 2017;16(6):413-8.
20. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63 Suppl 86:8-160.
21. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50(1):1-12.
22. Reeser JC, Willick S, Elstad M. Medical services provided at the Olympic Village polyclinic during the 2002 Salt Lake City Winter Games. WMJ : official publication of the State Medical Society of Wisconsin. 2003;102(4):20-5.
23. Robinson SR, Wormald PJ. Endoscopic vidian neurectomy. American journal of rhinology. 2006;20(2):197-202.
24. Nieman DC, Johanssen LM, Lee JW, Arabatzis K. Infectious episodes in runners before and after the Los Angeles Marathon. The Journal of sports medicine and physical fitness. 1990;30(3):316-28.
25. Gleeson M, Pyne DB, Austin JP, Lynn Francis J, Clancy RL, McDonald WA, et al. Epstein-Barr virus reactivation and upper-respiratory illness in elite swimmers. Medicine and science in sports and exercise. 2002;34(3):411-7.
26. Makela MJ, Puhakka T, Ruuskanen O, Leinonen M, Saikku P, Kimpimaki M, et al. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol. 1998;36(2):539-42.
27. Peters EM, Bateman ED. Ultramarathon running and upper respiratory tract infections. An epidemiological survey. S Afr Med J. 1983;64(15):582-4.
28. Peters EM, Shaik J, Kleinveldt N. Upper respiratory tract infection symptoms in ultramarathon runners not related to immunoglobulin status. Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine. 2010;20(1):39-46.
29. Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, Bishop NC, et al. Position statement. Part one: Immune function and exercise. Exercise immunology review. 2011;17:6-63.
30. Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet. 2011;378(9809):2112-22.
31. Surda P, Walker A, Limpens J, Fokkens W, Putala M. Nasal changes associated with exercise in athletes: systematic review. J Laryngol Otol. 2018;132(3):191-7.
32. Surda P, Walker A, Putala M, Siarnik P. Prevalence of Rhinitis in Athletes: Systematic Review. Int J Otolaryngol. 2017;2017:8098426.
33. Bernard A, Nickmilder M, Voisin C, Sardella A. Impact of chlorinated swimming pool attendance on the respiratory health of adolescents. Pediatrics. 2009;124(4):1110-8.
34. Hox V, Vanoirbeek JA, Alpizar YA, Voedisch S, Callebaut I, Bobic S, et al. Crucial role of transient receptor potential ankyrin 1 and mast cells in induction of nonallergic airway hyperreactivity in mice. Am J Respir Crit Care Med. 2013;187(5):486-93.
35. Lakier Smith L. Overtraining, excessive exercise, and altered immunity: is this a T helper-1 versus T helper-2 lymphocyte response? Sports Med. 2003;33(5):347-64.
36. Steensberg A, Toft AD, Bruunsgaard H, Sandmand M, Halkjaer-Kristensen J, Pedersen BK. Strenuous exercise decreases the percentage of type 1 T cells in the circulation. J Appl Physiol (1985). 2001;91(4):1708-12.
37. Bachert C, Van Cauwenberghe P, Olbrecht J, Van Schoor J. Prevalence, Classification and Perception of Allergic and Non-allergic Rhinitis. Allergy. 2006;61(6):693-8.
38. Gelardi M, Ventura MT, Fiorella R, Fiorella ML, Russo C, Candreva T, et al. Allergic and non-allergic rhinitis in swimmers: clinical and cytological aspects. Br J Sports Med. 2012;46(1):54-8.
39. Ottaviano G, Staffieri A, Stritoni P, Ermolao A, Coles S, Zaccaria M, et al. Nasal dysfunction induced by chlorinate water in competitive swimmers. Rhinology. 2012;50(3):294-8.
40. Cavalcante de Sa M, Nakagawa NK, Saldiva de Andre CD, Carvalho-Oliveira R, de Santana Carvalho T, Nicola ML, et al. Aerobic exercise in polluted urban environments: effects on airway defense mechanisms in young healthy amateur runners. Journal of breath research. 2016;10(4):046018.
41. Santos J, Foster R, Jonckheere AC, Rossi M, Luna Junior LA, Katekaru CM, et al. Outdoor Endurance Training with Air Pollutant Exposure Versus Sedentary Lifestyle: A Comparison of Airway Immune Responses. International journal of environmental research and public health. 2019;16(22).
42. Baraniuk JN, Merck SJ. Nasal reflexes: implications for exercise, breathing, and sex. Current allergy and asthma reports. 2008;8(2):147-53.
43. Jones AS. Autonomic reflexes and non-allergic rhinitis. Allergy. 1997;52(36 Suppl):14-9.
44. Muns G, Rubinstein I, Singer P. Neutrophil chemotactic activity is increased in nasal secretions of long-distance runners. International journal of sports medicine. 1996;17(1):56-9.
45. Doulaptsi M, Steelant B, Prokopakis E, Ierodiakonou D, Tsinaslanidou Z, Cools L, et al. Prevalence and impact of nasal hyperreactivity in chronic rhinosinusitis. Allergy. 2020.
46. Van Gerven L, Steelant B, Hellings PW. Nasal hyperreactivity in rhinitis: A diagnostic and therapeutic challenge. Allergy. 2018.
47. Van Gerven L, Boeckxstaens G, Jorissen M, Fokkens W, Hellings PW. Short-time cold dry air exposure: a useful diagnostic tool for nasal hyperresponsiveness. Laryngoscope. 2012;122(12):2615-20.
48. Bonadonna P, Senna G, Zanon P, Cocco G, Dorizzi R, Gani F, et al. Cold-induced rhinitis in skiers–clinical aspects and treatment with ipratropium bromide nasal spray: a randomized controlled trial. American journal of rhinology. 2001;15(5):297-301.
49. Sonmez G, Uzun G, Mutluoglu M, Toklu AS, Mutlu H, Ay H, et al. Paranasal sinus mucosal hypertrophy in experienced divers. Aviation, space, and environmental medicine. 2011;82(10):992-4.
50. Fischer H, Gubisch W. Nasal valves–importance and surgical procedures. Facial plastic surgery : FPS. 2006;22(4):266-80.
51. Chen XB, Lee HP, Chong VF, Wang de Y. Impact of inferior turbinate hypertrophy on the aerodynamic pattern and physiological functions of the turbulent airflow - a CFD simulation model. Rhinology. 2010;48(2):163-8.
52. Passàli D, Damiani V, Passàli GC, Passàli FM, Bellussi L. Alterations in rhinosinusal homeostasis in a sportive population: our experience with 106 athletes. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2004;261(9):502-6.
53. Hellings PW, Scadding G, Alobid I, Bachert C, Fokkens WJ, Gerth van Wijk R, et al. Executive summary of European Task Force document on diagnostic tools in rhinology. Rhinology. 2012;50(4):339-52.
54. Hamilton GS, 3rd. The External Nasal Valve. Facial plastic surgery clinics of North America. 2017;25(2):179-94.
55. Ottaviano G, Fokkens WJ. Measurements of nasal airflow and patency: a critical review with emphasis on the use of peak nasal inspiratory flow in daily practice. Allergy. 2016;71(2):162-74.
56. Bonini S, Bonini M, Bousquet J, Brusasco V, Canonica GW, Carlsen KH, et al. Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN. Allergy. 2006;61(6):681-92.
57. Jonckheere AC, Seys SF, Dilissen E, Marijsse G, Schelpe AS, Van der Eycken S, et al. AQUA((c)) Questionnaire as prediction tool for atopy in young elite athletes. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2018;29(6):648-50.
58. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3):466-76.
59. Auge J, Vent J, Agache I, Airaksinen L, Campo Mozo P, Chaker A, et al. EAACI Position paper on the standardization of nasal allergen challenges. Allergy. 2018;73(8):1597-608.
60. Hellings PW, Klimek L, Cingi C, Agache I, Akdis C, Bachert C, et al. Non-allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2017;72(11):1657-65.
61. World anti-doping code, (2020).
62. Santos A CM, Delgado L. Best buys for allergic rhinitis and chronic rhinosinusitis prevention and control. In: Akdis CA HP, Agache I, editor. Global atlas of allergic rhinitis and chronic rhinosinusitis: European Academy of Allergy and Clinical Immunology; 2015.
63. Fantuzzi G, Righi E, Predieri G, Giacobazzi P, Petra B, Aggazzotti G. Airborne trichloramine (NCl(3)) levels and self-reported health symptoms in indoor swimming pool workers: dose-response relationships. Journal of exposure science & environmental epidemiology. 2013;23(1):88-93.
64. Seys SF, Feyen L, Keirsbilck S, Adams E, Dupont LJ, Nemery B. An outbreak of swimming-pool related respiratory symptoms: An elusive source of trichloramine in a municipal indoor swimming pool. International journal of hygiene and environmental health. 2015;218(4):386-91.
65. WHO. Guidelines for safe recreational water environments. Volume 2, Swimming pools and similar environments. In: Organization WH, editor. 2006.
66. Katelaris CH, Carrozzi FM, Burke TV, Byth K. Effects of intranasal budesonide on symptoms, quality of life, and performance in elite athletes with allergic rhinoconjunctivitis. Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine. 2002;12(5):296-300.
67. Hox V, Lourijsen E, Jordens A, Aasbjerg K, Agache I, Alobid I, et al. Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper. Clinical and translational allergy. 2020;10:1.
68. Simons FE. Advances in H1-antihistamines. The New England journal of medicine. 2004;351(21):2203-17.
69. Banov CH, Lieberman P, Vasomotor Rhinitis Study G. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2001;86(1):28-35.
70. Gehanno P, Deschamps E, Garay E, Baehre M, Garay RP. Vasomotor rhinitis: clinical efficacy of azelastine nasal spray in comparison with placebo. ORL J Otorhinolaryngol Relat Spec. 2001;63(2):76-81.
71. Price D, Shah S, Bhatia S, Bachert C, Berger W, Bousquet J, et al. A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis. Journal of investigational allergology & clinical immunology. 2013;23(7):495-503.
72. Kortekaas Krohn I, Callebaut I, Alpizar YA, Steelant B, Van Gerven L, Skov PS, et al. MP29-02 reduces nasal hyperreactivity and nasal mediators in patients with house dust mite-allergic rhinitis. Allergy. 2018;73(5):1084-93.
73. Farre M, Perez-Mana C, Papaseit E, Menoyo E, Perez M, Martin S, et al. Bilastine vs. hydroxyzine: occupation of brain histamine H1 -receptors evaluated by positron emission tomography in healthy volunteers. British journal of clinical pharmacology. 2014;78(5):970-80.
74. Passalacqua G, Bousquet J, Bachert C, Church MK, Bindsley-Jensen C, Nagy L, et al. The clinical safety of H1-receptor antagonists. An EAACI position paper. Allergy. 1996;51(10):666-75.
75. Philip G, Nayak AS, Berger WE, Leynadier F, Vrijens F, Dass SB, et al. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Current medical research and opinion. 2004;20(10):1549-58.
76. Roberts G, Pfaar O, Akdis CA, Ansotegui IJ, Durham SR, Gerth van Wijk R, et al. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis. Allergy. 2018;73(4):765-98.
77. Lekakis G, Dekimpe E, Steelant B, Hellings PW. Managing nasal valve compromise patients with nasal dilators: objective vs. subjective parameters. Rhinology. 2016;54(4):348-54.
78. Dinardi RR, de Andrade CR, Ibiapina Cda C. External nasal dilators: definition, background, and current uses. International journal of general medicine. 2014;7:491-504.
79. Gelardi M, Porro G, Accettura D, Quaranta VN, Quaranta N, Ciprandi G. The role of an internal nasal dilator in athletes. Acta bio-medica : Atenei Parmensis. 2019;90(2-s).
80. Tong TK, Fu FH, Chow BC. Nostril dilatation increases capacity to sustain moderate exercise under nasal breathing condition. The Journal of sports medicine and physical fitness. 2001;41(4):470-8.
81. Ottaviano G, Ermolao A, Nardello E, Muci F, Favero V, Zaccaria M, et al. Breathing parameters associated to two different external nasal dilator strips in endurance athletes. Auris, nasus, larynx. 2017;44(6):713-8.
82. Dinardi RR, de Andrade CR, Ibiapina Cda C. Evaluation of the effectiveness of the external nasal dilator strip in adolescent athletes: a randomized trial. International journal of pediatric otorhinolaryngology. 2013;77(9):1500-5.
83. van Egmond M, Rovers MM, Tillema AHJ, van Neerbeek N. Septoplasty for nasal obstruction due to a deviated nasal septum in adults: a systematic review. Rhinology. 2018;56(3):195-208.
84. Lennon P, Jaber S, Fenton JE. Functional and psychological impact of nasal bone fractures sustained during sports activities: A survey of 87 patients. Ear, nose, & throat journal. 2016;95(8):324-32.
85. Bonini M, Bachert C, Baena-Cagnani CE, Bedbrook A, Brozek JL, Canonica GW, et al. What we should learn from the London Olympics. Curr Opin Allergy Clin Immunol. 2013;13(1):1-3.
86. Hellings PW, Fokkens WJ, Bachert C, Akdis CA, Bieber T, Agache I, et al. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017;72(9):1297-305.
87. Hens G, Hellings PW. The nose: gatekeeper and trigger of bronchial disease. Rhinology. 2006;44(3):179-87.
88. Stickland MK, Rowe BH, Spooner CH, Vandermeer B, Dryden DM. Effect of warm-up exercise on exercise-induced bronchoconstriction. Medicine and science in sports and exercise. 2012;44(3):383-91.
89. Seys SF, Bousquet J, Bachert C, Fokkens WJ, Agache I, Bernal-Sprekelsen M, et al. mySinusitisCoach: patient empowerment in chronic rhinosinusitis using mobile technology. Rhinology. 2018;56(3):209-15.